In addition, TNF-α may represent a metabolite, providing cross-talk between inflammatory adipose tissue and high cardiometabolic risk, as patients with rheumatoid arthritis responding to anti-TNF-α therapy had a lower frequency of myocardial infarction compared to non-responders [43]. This evidence concerns the gene TNF and myocardial infarction.